An official website of the United States government
PAR-25-183 - Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 2
Active NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|
Expired NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition Insecurity | NOT-OD-22-135 | ONR FIC NCI NHLBI NIAMS NICHD NIDCR NIDDK NIMH NIMHD NINR OAR OBSSR ODP ODS PN ORWH | Jun 21, 2022 | Nov 29, 2024 | R01, 333, R21, K01, R34, R33, R61/R33, UG3/UH3, K43 |
| Notice of Special Interest: NIMH Priorities on Research on Aggression and Violence Against Others | NOT-MH-22-095 | NIMH | Feb 3, 2022 | Jan 8, 2025 | R36, R01, R34, R21, F32, R21/R33, R03, R61/R33, U01, K08, R15, K23, P50, F30, K99/R00, F31, K22, K01 |
